Lacosam 15mg Syrup contains lacosamide, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Each milliliter of the syrup formulation provides 15 mg of lacosamide, facilitating precise dosing and ease of administration, particularly in pediatric and adult patients who have difficulty swallowing tablets. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes, and inhibiting repetitive neuronal firing, thereby reducing seizure frequency. The syrup is typically initiated at a low dose and titrated gradually to minimize adverse effects, with dosing individualized based on clinical response and tolerability. Common adverse reactions may include dizziness, headache, nausea, and fatigue; serious side effects are rare but may involve cardiac conduction abnormalities, necessitating caution in patients with pre-existing cardiac conditions. Lacosam 15mg Syrup should be used under strict medical supervision, with regular monitoring of therapeutic response and potential side effects. It is contraindicated in patients with known hypersensitivity to lacosamide or any excipients. This formulation provides a valuable option for seizure management, offering flexibility in dosing and improved compliance in patients requiring antiepileptic therapy.